The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma

NCT06266832 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma

Interventions

DRUG: Adebrelimab
DRUG: Oxaliplatin
DRUG: Capecitabine
RADIATION: Short-course Radiation
PROCEDURE: Biopsy

Sponsor

Sir Run Run Shaw Hospital